Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Special use-results survey of ENAROY Tablets (long-term use)
jRCT2031210549Active, not recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of enarodustat in anemia of renal disease, sponsored by Shionogi & Co., Ltd. Primary endpoints: Incidence of onset of thromboembolism, Incidence of onset of hypertension and 4 more. Started Mar 2022; status: active, not recruiting.
02
Drugs
enarodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2031210549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210549.